Xi Liang Song
Director/Board Member at QINGDAO SENTURY TIRE CO., LTD.
Profile
Xi Liang Song is currently an Independent Director at Qingdao Sentury Tire Co., Ltd., an Independent Director at Yantai Zhenghai Bio-Tech Co., Ltd., an Independent Director at MabPlex International Co., Ltd., a Professor at Shandong University of Finance, a Council Member at Chinese Institute of Finance, a Council Member at Cost for Young & Mid-Career Professionals, and a Council Member at Shandong Chamber of Accounting.
Previously, Dr. Song served as an Independent Director at Shandong Zhonglu Oceanic Fisheries Co., Ltd., an Independent Director at Weihai Huadong Automation Co., Ltd., an Independent Director at Shandong Sacred Sun Power Sources Co., Ltd., and an Independent Non-Executive Director at Shandong Weigao Blood Purification Products Co., Ltd.
Dr. Song obtained a graduate degree from Tianjin University of Finance & Economics in 2001, a doctorate degree from Beijing Jiaotong University in 2010, and an undergraduate degree from Shandong University of Finance & Economics in 1989.
Xi Liang Song active positions
| Companies | Position | Start |
|---|---|---|
| QINGDAO SENTURY TIRE CO., LTD. | Director/Board Member | 17/11/2017 |
| YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD. | Director/Board Member | - |
| Chinese Institute of Finance | Corporate Officer/Principal | - |
| Cost for Young & Mid-Career Professionals | Corporate Officer/Principal | - |
| Shandong Chamber of Accounting | Corporate Officer/Principal | - |
| Shandong University of Finance | Corporate Officer/Principal | - |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Director/Board Member | 31/12/2021 |
Former positions of Xi Liang Song
| Companies | Position | End |
|---|---|---|
| WEIHAI HUADONG AUTOMATION CO., LTD | Director/Board Member | 28/02/2021 |
| SHANDONG SACRED SUN POWER SOURCES CO.,LTD | Director/Board Member | 23/12/2019 |
| ░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Xi Liang Song
| Tianjin University of Finance & Economics | Graduate Degree |
| Beijing Jiaotong University | Doctorate Degree |
| Shandong University of Finance & Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| SHANDONG ZHONGLU OCEANIC FISHERIES COMPANY LIMITED | Consumer Non-Durables |
| WEIHAI HUADONG AUTOMATION CO., LTD | Technology Services |
| SHANDONG SACRED SUN POWER SOURCES CO.,LTD | Producer Manufacturing |
| QINGDAO SENTURY TIRE CO., LTD. | Consumer Durables |
| YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD. | Health Technology |
| Private companies | 5 |
|---|---|
| Chinese Institute of Finance | |
| Cost for Young & Mid-Career Professionals | |
| Shandong Chamber of Accounting | |
Shandong Weigao Blood Purification Products Co., Ltd.
 Shandong Weigao Blood Purification Products Co., Ltd. Medical SpecialtiesHealth Technology Shandong Weigao Blood Purification Products Co., Ltd. engages in providing blood purification products. It offers dialyzers, hemodialysis machines, bloodlines, and peritoneal dialysis solutions. Its end users include hospitals and dialysis centers. The company was founded on December 27, 2004 and is headquartered in Weihai, China. | Health Technology |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
- Stock Market
- Insiders
- Xi Liang Song
